Position in SNGX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$83
-$163 QoQ
Shares Held
209
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 13 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Plante Moran Financial Advisors, LLC holds $543,889 across 38 Biotechnology names. SNGX ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLAY |
Relay Therapeutics, Inc.
|
10,836 | $202,741 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
636 | $191,455 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
171 | $84,940 | |
| 4 | SABS |
SAB Biotherapeutics, Inc.
|
5,925 | $23,107 | |
| 5 | OMER |
Omeros Corp
|
1,000 | $9,510 | |
| 6 | ARGX |
Argenx SE
|
7 | $6,494 | |
| 7 | BHVN |
Biohaven Ltd.
|
362 | $5,386 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
6 | $2,230 |
All Filings in SNGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83 | 209 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $246 | 209 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $280 | 209 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $242 | 209 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $393 | 300 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $645 | 300 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $810 | 300 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,191 | 300 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $774 | 300 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,866 | 4,778 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,631 | 4,778 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,675 | 4,778 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $3,344 | 4,778 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $9,412 | 4,778 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $32,246 | 71,658 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $31,529 | 71,658 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $42,994 | 71,658 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $52,310 | 71,658 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $47,294 | 71,658 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $75,957 | 71,658 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $79,540 | 71,658 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $109,636 | 71,658 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $91,722 | 71,658 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $128,267 | 71,658 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $151,198 | 71,658 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $120,385 | 71,658 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||